Breaking News Instant updates and real-time market news.

SPH

Suburban Propane

$31.94

0.24 (0.76%)

06:09
10/13/16
10/13
06:09
10/13/16
06:09

Suburban Propane upgraded to Buy from Hold at Stifel

SPH Suburban Propane
$31.94

0.24 (0.76%)

06/10/16
UBSW
06/10/16
DOWNGRADE
Target $35
UBSW
Neutral
Suburban Propane downgraded to Neutral from Buy at UBS
UBS analyst Shneur Gershuni downgraded Suburban Propane Partners to Neutral saying the stock looks fairly valued at current levels. The analyst keeps a $35 price target for the shares.
06/10/16
06/10/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on the today's top five analyst downgrades with this list compiled by The Fly: 1. Zoetis (ZTS) downgraded to Neutral from Buy at Citi by analyst Liav Abraham, who cited valuation, as she views the stock as fairly valued at current levels. The stock has significantly outperformed the specialty pharma group year-to-date, Abraham said, adding that she remains constructive on the company's fundamentals. The analyst increased her price target for shares to $50 from $46. 2. AbbVie (ABBV) downgraded to Market Perform from Outperform by BMO Capital, which cut its target on shares to $66 from $70. In the wake of events at ASCO, disclosures at AbbVie's R&D day, and statements from Eli Lilly (LLY) and Pfizer (PFE), the firm is more concerned about the longer term outlook for AbbVie's immunology franchise, especially Humira. 3. AmeriGas (APU) downgraded to Sell from Neutral at UBS by analyst Shneur Gershuni, who said the stock looks relatively expensive at current levels and that its yield is lower than competitors. The analyst, who kept a $39 price target on shares, also downgraded Ferrellgas Partners (FGP) to Sell and Suburban Propane (SPH) to Neutral. 4. J.M. Smucker (SJM) downgraded to Hold from Buy at Jefferies by analyst Akshay Jagdale, who raised his price target for shares to $143 from $140. The analyst views the stock's risk/reward as balanced at current levels amid rising commodity costs and the management transition. 5. Mattress Firm (MFRM) downgraded to Market Perform from Outperform at Raymond James by analyst Budd Bugatch following the Q1 report and conference call. The analyst said the Sleepy's integration, a move to a new corporate headquarters, and merchandising push to more proprietary products have increased near-term earnings risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/20/16
JANY
07/20/16
DOWNGRADE
Target $30
JANY
Neutral
Suburban Propane downgraded to Neutral from Buy at Janney Capital
Janney Capital analyst Michael Gyure assumed coverage of Suburban Propane with a Neutral rating and $30 fair value estimate, down from the firm's prior Buy rating and $33 fair value estimate. Gyure believes Suburban's unique infrastructure assets generate the most significant earnings and cash flow during the winter season and rates the units as a Neutral as we enter the seasonally lower fiscal second half. If there is not a significantly colder winter than last year, he believes Suburban will have to sell non-core assets or significantly reduce its cost structure.
07/20/16
JANY
07/20/16
DOWNGRADE
JANY
Neutral
Suburban Propane downgraded to Neutral from Buy at Janney Capital
Janney Capital analyst Michael Gyure assumed coverage on Suburban Propane with a Neutral rating from a Buy rating and lowered its price target to $30 from $33. The analyst said the Street is potentially modeling in significant year-over-year volume and pricing recoveries in the propane business for fiscal 1H 2017 that may not be achievable if this year's winter season is not significantly colder than last years.

TODAY'S FREE FLY STORIES

NVDQ

Novadaq

$6.59

-0.01 (-0.15%)

, CI

Cigna

$146.52

2.96 (2.06%)

15:57
02/21/17
02/21
15:57
02/21/17
15:57
Hot Stocks
LifeNet says Dermacell receives coverage from Cigna »

Cigna (CI) now covers…

NVDQ

Novadaq

$6.59

-0.01 (-0.15%)

CI

Cigna

$146.52

2.96 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

  • 28

    Feb

PBYI

Puma Biotechnology

$40.25

2.9 (7.76%)

15:56
02/21/17
02/21
15:56
02/21/17
15:56
Options
Puma Biotechnology put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 21

    Jul

SODA

SodaStream

$47.14

-0.53 (-1.11%)

15:54
02/21/17
02/21
15:54
02/21/17
15:54
Hot Stocks
Teleios Capital lowers stake in SodaStream to 4.5% »

Teleios Capital has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOMO

Momo

$27.00

0.2 (0.75%)

15:48
02/21/17
02/21
15:48
02/21/17
15:48
Hot Stocks
Matrix Partners China lowers stake in Momo to 12.6% from 15.4% »

On September 23, 2016,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

BMY

Bristol-Myers

$53.55

-1.04 (-1.91%)

15:38
02/21/17
02/21
15:38
02/21/17
15:38
Hot Stocks
Breaking Hot Stocks news story on Bristol-Myers »

Bristol-Myers up 2.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 02

    Mar

  • 17

    Mar

  • 01

    Apr

BMY

Bristol-Myers

$53.54

-1.05 (-1.92%)

15:38
02/21/17
02/21
15:38
02/21/17
15:38
Periodicals
Carl Icahn takes stake in Bristol-Myers, WSJ reports »

Icahn sees value in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 02

    Mar

  • 17

    Mar

  • 01

    Apr

DEPO

Depomed

$16.47

-0.38 (-2.26%)

15:35
02/21/17
02/21
15:35
02/21/17
15:35
Options
Depomed options imply 6.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

CSCO

Cisco

$33.74

0.14 (0.42%)

15:32
02/21/17
02/21
15:32
02/21/17
15:32
Conference/Events
Cisco to host service provider tech talk »

Cisco SVP Kanouff hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 03

    Mar

EFA

iShares MSCI EAFE Index Fund

$60.65

0.15 (0.25%)

15:31
02/21/17
02/21
15:31
02/21/17
15:31
Options
Defensive option play opened in the iShares MSCI EAFE Fund »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUAN

Nuance

$16.96

0.1 (0.59%)

15:26
02/21/17
02/21
15:26
02/21/17
15:26
Options
Nuance call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$8.85

0.55 (6.63%)

15:25
02/21/17
02/21
15:25
02/21/17
15:25
Conference/Events
Cantor Fitzgerald health/pharma analysts hold analyst/industry conference call »

Analysts, along with Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 13

    Mar

$NSD

NASDAQ Market Internals

15:21
02/21/17
02/21
15:21
02/21/17
15:21
Technical Analysis
NASDAQ Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:21
02/21/17
02/21
15:21
02/21/17
15:21
Technical Analysis
NYSE Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENT

Global Eagle

$6.22

-0.01 (-0.16%)

15:21
02/21/17
02/21
15:21
02/21/17
15:21
Downgrade
Global Eagle rating change  »

Global Eagle downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 06

    Mar

ARLZ

Aralez

$4.50

-0.02 (-0.44%)

, AMGN

Amgen

$173.29

1.18 (0.69%)

15:20
02/21/17
02/21
15:20
02/21/17
15:20
Hot Stocks
Bass group fails to prove Aralez patent claims unpatentable »

The Coalition For…

ARLZ

Aralez

$4.50

-0.02 (-0.44%)

AMGN

Amgen

$173.29

1.18 (0.69%)

BIIB

Biogen

$288.94

-1.19 (-0.41%)

ABBV

AbbVie

$61.66

-0.1147 (-0.19%)

JNJ

Johnson & Johnson

$119.49

0.63 (0.53%)

SHPG

Shire

$181.08

2.38 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 24

    Feb

  • 06

    Mar

  • 07

    Mar

  • 09

    Mar

  • 14

    Mar

  • 17

    Mar

  • 21

    Mar

  • 27

    Mar

  • 01

    Apr

  • 26

    Jun

  • 19

    Jul

HCLP

Hi-Crush Partners

$21.58

0.275 (1.29%)

15:20
02/21/17
02/21
15:20
02/21/17
15:20
Options
Hi Crush options imply 9.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

TWTR

Twitter

$16.42

-0.2 (-1.20%)

15:18
02/21/17
02/21
15:18
02/21/17
15:18
Hot Stocks
Twitter head of entertainment talent resigns »

Lara Cohen, head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 23

    Feb

  • 28

    Feb

  • 19

    Mar

KRP

Kimbell Royalty Partners

$19.90

0.15 (0.76%)

15:16
02/21/17
02/21
15:16
02/21/17
15:16
Hot Stocks
Breaking Hot Stocks news story on Kimbell Royalty Partners »

Rivercrest Royalties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$36.07

-0.09 (-0.25%)

15:16
02/21/17
02/21
15:16
02/21/17
15:16
Options
Goodyear Tire put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$20.11

-0.06 (-0.30%)

15:16
02/21/17
02/21
15:16
02/21/17
15:16
Conference/Events
Barrick Gold to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MARA

Marathon Patent Group

$1.34

-0.04 (-2.90%)

, HON

Honeywell

$124.79

0.2317 (0.19%)

15:15
02/21/17
02/21
15:15
02/21/17
15:15
Hot Stocks
Marathon Patent unit files patent infringement suits against Honeywell, Somfy »

Marathon Patent Group…

MARA

Marathon Patent Group

$1.34

-0.04 (-2.90%)

HON

Honeywell

$124.79

0.2317 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 01

    Mar

  • 29

    Mar

  • 24

    Apr

15:15
02/21/17
02/21
15:15
02/21/17
15:15
General news
Breaking General news story  »

San Francisco Federal…

RDS.A

Royal Dutch Shell

$52.48

0.275 (0.53%)

15:13
02/21/17
02/21
15:13
02/21/17
15:13
Conference/Events
Royal Dutch Shell to hold a conference call »

EVP of Gas and Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBYI

Puma Biotechnology

$40.25

2.9 (7.76%)

, RHHBY

Roche

$30.53

0.02 (0.07%)

15:11
02/21/17
02/21
15:11
02/21/17
15:11
Hot Stocks
Before the Move: Watch Puma Biotech into data on breast cancer rival »

Ahead of Roche's…

PBYI

Puma Biotechnology

$40.25

2.9 (7.76%)

RHHBY

Roche

$30.53

0.02 (0.07%)

IBB

iShares Nasdaq Biotechnology Index

$294.35

1.37 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

  • 09

    Mar

  • 26

    Jun

  • 21

    Jul

XPO

XPO Logistics

$48.50

-0.72 (-1.46%)

15:05
02/21/17
02/21
15:05
02/21/17
15:05
Options
XPO Logistics options imply 10.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.